151 related articles for article (PubMed ID: 21320466)
1. hERG channel blockade by externally applied quaternary ammonium derivatives.
Choi KH; Song C; Shin D; Park S
Biochim Biophys Acta; 2011 Jun; 1808(6):1560-6. PubMed ID: 21320466
[TBL] [Abstract][Full Text] [Related]
2. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
[TBL] [Abstract][Full Text] [Related]
3. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
Haraguchi Y; Ohtsuki A; Oka T; Shimizu T
BMC Pharmacol Toxicol; 2015 Dec; 16():39. PubMed ID: 26671227
[TBL] [Abstract][Full Text] [Related]
5. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HERG potassium channels by domiphen bromide and didecyl dimethylammonium bromide.
Long Y; Chen W; Lin Z; Sun H; Xia M; Zheng W; Li Z
Eur J Pharmacol; 2014 Aug; 737():202-9. PubMed ID: 24846011
[TBL] [Abstract][Full Text] [Related]
7. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the human ether-a-go-go-related gene potassium channel by ketamine.
Zhang P; Xing J; Luo A; Feng J; Liu Z; Gao C; Ma J
J Pharm Pharmacol; 2013 Sep; 65(9):1321-8. PubMed ID: 23927470
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
[TBL] [Abstract][Full Text] [Related]
10. Hirsutenone directly blocks human ether-a-go-go related gene K+ channels.
Yun J; Bae H; Choi SE; Kim JH; Choi YW; Lim I; Lee CS; Lee MW; Ko JH; Seo SJ; Bang H
Biol Pharm Bull; 2011; 34(12):1815-22. PubMed ID: 22130236
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
12. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC
J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
[TBL] [Abstract][Full Text] [Related]
14. Assessment of temperature-induced hERG channel blockade variation by drugs.
Kauthale RR; Dadarkar SS; Husain R; Karande VV; Gatne MM
J Appl Toxicol; 2015 Jul; 35(7):799-805. PubMed ID: 25348819
[TBL] [Abstract][Full Text] [Related]
15. The human ether-a'-go-go related gene (hERG) K+ channel blockade by the investigative selective-serotonin reuptake inhibitor CONA-437: limited dependence on S6 aromatic residues.
Alexandrou AJ; Milnes JT; Sun SZ; Fermini B; Kim SC; Jenkinson S; Leishman DJ; Witchel HJ; Hancox JC; Leaney JL
J Physiol Pharmacol; 2014 Aug; 65(4):511-23. PubMed ID: 25179083
[TBL] [Abstract][Full Text] [Related]
16. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
17. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
Milnes JT; Witchel HJ; Leaney JL; Leishman DJ; Hancox JC
J Pharmacol Toxicol Methods; 2010; 61(2):178-91. PubMed ID: 20172036
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.
Long Y; Lin Z; Xia M; Zheng W; Li Z
Toxicol Appl Pharmacol; 2013 Mar; 267(2):155-66. PubMed ID: 23313619
[TBL] [Abstract][Full Text] [Related]
19. Effects of common antitussive drugs on the hERG potassium channel current.
Deisemann H; Ahrens N; Schlobohm I; Kirchhoff C; Netzer R; Möller C
J Cardiovasc Pharmacol; 2008 Dec; 52(6):494-9. PubMed ID: 19034038
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of liensinine and neferine on the human ether-a-go-go-related gene potassium channel and pharmacological activity analysis.
Dong ZX; Zhao X; Gu DF; Shi YQ; Zhang J; Hu XX; Hu MQ; Yang BF; Li BX
Cell Physiol Biochem; 2012; 29(3-4):431-42. PubMed ID: 22508050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
